(Q36564507)

English

Role of Omega-3 fatty acids in preventing metabolic disturbances in patients on olanzapine plus either sodium valproate or lithium: a randomized double-blind placebo-controlled trial

scientific article published on 4 October 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 August 2017

Role of Omega-3 fatty acids in preventing metabolic disturbances in patients on olanzapine plus either sodium valproate or lithium: a randomized double-blind placebo-controlled trial (English)

1 reference

Europe PubMed Central

15 August 2017

0 references

0 references

Shahin Akhondzadeh

object named as

Shahin Akhondzadeh

5

0 references

author name string

Toktam Faghihi

1

1 reference

Europe PubMed Central

15 August 2017

Adel Jahed

2

1 reference

Europe PubMed Central

15 August 2017

Javad Mahmoudi-Gharaei

3

1 reference

Europe PubMed Central

15 August 2017

Vandad Sharifi

4

1 reference

Europe PubMed Central

15 August 2017

Padideh Ghaeli

6

1 reference

Europe PubMed Central

15 August 2017

language of work or name

0 references

publication date

4 October 2012

1 reference

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

15 August 2017

20

1 reference

Europe PubMed Central

15 August 2017

1

1 reference

Europe PubMed Central

15 August 2017

43

1 reference

Europe PubMed Central

15 August 2017

copyright license

Creative Commons Attribution 2.0 Generic

4 October 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

https://scigraph.springernature.com/pub.10.1186/2008-2231-20-43

0 references

Effect of Early Intervention with Omega-3 on Insulin Resistance in Patients Initiated on Olanzapine with either Sodium Valproate or Lithium: A randomized, Double-blind, Placebo-Controlled Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555734

30 September 2017

Valproate-associated coagulopathies in children during short-term treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555734

30 September 2017

Relative atherogenicity and predictive value of non-high-density lipoprotein cholesterol for coronary heart disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555734

30 September 2017

A systematic review of the impact of n-3 fatty acids in bone health and osteoporosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555734

30 September 2017

Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555734

30 September 2017

Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555734

30 September 2017

Prescription omega-3 fatty acids for the treatment of hypertriglyceridemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555734

30 September 2017

Fish intake, contaminants, and human health: evaluating the risks and the benefits

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555734

30 September 2017

Antiatherosclerotic and antithrombotic effects of omega-3 fatty acids

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555734

30 September 2017

n-3 fatty acids and the metabolic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555734

30 September 2017

Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555734

30 September 2017

n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555734

30 September 2017

Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555734

30 September 2017

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555734

30 September 2017

Changes in body weight and body mass index among psychiatric patients receiving lithium, valproate, or topiramate: an open-label, nonrandomized chart review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555734

30 September 2017

n-3 polyunsaturated fatty acids and coronary thrombosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555734

30 September 2017

Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555734

30 September 2017

Fish oil and cardiovascular disease: lipids and arterial function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555734

30 September 2017

Arterial stiffness and stroke in hypertension: therapeutic implications for stroke prevention

1 reference

https://api.crossref.org/works/10.1186%2F2008-2231-20-43

21 January 2018

Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls

1 reference

https://api.crossref.org/works/10.1186%2F2008-2231-20-43

21 January 2018

High prevalence of metabolic disturbances in patients with bipolar disorder in Taiwan

1 reference

https://api.crossref.org/works/10.1186%2F2008-2231-20-43

21 January 2018

Obesity and metabolic syndrome in a psychiatric rehabilitation service.

1 reference

https://api.crossref.org/works/10.1186%2F2008-2231-20-43

21 January 2018

Weight change in the acute treatment of bipolar I disorder: a naturalistic observational study of psychiatric inpatients

1 reference

https://api.crossref.org/works/10.1186%2F2008-2231-20-43

21 January 2018

Severe mental illness and risk of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1186%2F2008-2231-20-43

21 January 2018

Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1186%2F2008-2231-20-43

21 January 2018

Metabolic syndrome in bipolar disorder: a cross-sectional assessment of a Health Management Organization database

1 reference

https://api.crossref.org/works/10.1186%2F2008-2231-20-43

21 January 2018

Effect of Antiepileptic drugs on plasma lipoprotein (a) and other lipid levels in childhood

1 reference

https://api.crossref.org/works/10.1186%2F2008-2231-20-43

21 January 2018

Thrombophilic risk factors in epileptic children treated with valproic Acid

1 reference

https://api.crossref.org/works/10.1186%2F2008-2231-20-43

21 January 2018

Rosiglitazone in the assistance of metabolic control during olanzapine administration in schizophrenia: a pilot double-blind, placebo-controlled, 12-week trial

1 reference

https://api.crossref.org/works/10.1186%2F2008-2231-20-43

21 January 2018

Hematologic manifestations and impaired liver synthetic function during valproate monotherapy.

1 reference

https://api.crossref.org/works/10.1186%2F2008-2231-20-43

21 January 2018

Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555734

21 September 2018

Elevated plasma concentrations of lipoprotein(a) in medicated epileptic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23351198

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Omega-3 polyunsaturated fatty acids decrease plasma lipoprotein(a) levels in hypertensive subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/23351198

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolism and distribution of fibrinogen. I. Fibrinogen turnover in physiological conditions in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/23351198

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of effects of N-3 to N-6 fatty acids on serum level of lipoprotein(a) in patients with coronary artery disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/23351198

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of antiepileptic drugs on plasma lipids, lipoprotein (a), and liver enzymes

1 reference

https://pubmed.ncbi.nlm.nih.gov/23351198

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin counter-regulatory factors, fibrinogen and C-reactive protein during olanzapine administration: effects of the antidiabetic metformin

1 reference

https://pubmed.ncbi.nlm.nih.gov/23351198

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

C-reactive protein is associated with the severity of cognitive impairment but not of psychiatric symptoms in individuals with schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/23351198

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/2008-2231-20-43

1 reference

Europe PubMed Central

15 August 2017

Dimensions Publication ID

0 references

release_3wnbmkswqvgohhtptxc5ywbvmm

1 reference

https://api.fatcat.wiki/v0/release/3wnbmkswqvgohhtptxc5ywbvmm

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36564507&oldid=2144972441"